CVS Health Corp. raised its profit guidance for the year after second-quarter earnings topped Wall Street estimates, driven by better-than-expected medical costs in the company’s Aetna insurance business.
CVS Health Corp. shares fell after the company gave preliminary 2027 profit guidance that disappointed investors. This news overshadowed a better-than-expected second quarter report.
Broad Market Momentum & Defensive Pivots: This Week's Top ETF Flows
Medicare Made Weight-Loss Drugs $50 A Month—Now Amazon, CVS And Walmart Race To Fill Prescriptions
CVS Health Profits Hit $2.9 Billion As Firm Gets Handle On Aetna Costs
CVS Health Launches Eli Lilly GLP-1 Partnership, Lifts Outlook as Profit Increases
CVS raises annual profit forecast on improved drug revenues
CVS's Turnaround Faces Its Next Test